Inhalation Sciences Abs (publ.) labtech system installed at University of Copenhagen for research into new inhalable TB vaccine.

 

STOCKHOLM, SWEDEN – August 23, 2017. The University of Copenhagen, Department of Pharmacy is to install PreciseInhale, ISAB’s advanced R&D labtech system, for its research into inhaled pharmaceutical therapies against TBC.

Group Leader and Associate Professor at the Department, Camilla Foged: “Acquiring PreciseInhale will enable us to perform essential preclinical proof-of-concept immunogenicity, efficacy and toxicology studies of highly promising inhalable dry powder-based nanomedicine formulations that we have designed. Installing PreciseInhale in our labs at the Department of Pharmacy is an important milestone for us. It will allow us to advance our state-of-the-art nanomedicines towards first-in-man studies. The aim of our research is to design a new thermostable, dry powder-based and inhalable vaccine against tuberculosis, and a nanoparticle-based anti-inflammatory formulation for the treatment of chronic obstructive pulmonary disease”.

The research is funded by the Independent Research Fund Denmark, the Innovative Medicines Initiative (IMI) project COMPACT (EU FP7), the Hørslev Foundation (Denmark), the Lundbeck Foundation (Denmark), and the Novo Nordisk Foundation (Denmark). The Department of Pharmacy is an innovative research and teaching unit. It carries out drug-development research on pharmaceutical technology and formulation, drug delivery and advanced drug analysis—as well as research-based teaching.

Previous purchasers of PreciseInhale include King’s College London, Karolinska Institute and Dow Chemical Group. ISAB CEO Fredrik Sjövall: “Every new installation is a powerful sign of how well-known PreciseInhale is becoming in the research community. We’re very proud that another prestigious academic research group has seen the value—and joined the pioneers already using PreciseInhale.”

Fredrik Sjövall
CEO 

fredrik.sjovall@inhalation.se
+46 (0)70 64 508 75

About Inhalation Sciences AB (publ.)

Inhalation Sciences develops and sells patented, highly innovative labtech equipment for inhalation research. Scientists using it can now know, with unprecedented accuracy, how particles behave in our lungs when we inhale them: whether new pollutants or life-saving drugs that power human development.

About the University of Copenhagen, Department of Pharmacy

The mission of the Department of Pharmacy is to advance the pharmaceutical sciences by performing drug-related research and research-based teaching within a range of topics including pharmaceutical technology and formulation, drug delivery, advanced drug analysis and clinical and social pharmacy. The Department emphasizes further development of internationally recognized programs of research and education. We are committed to serving the Danish society and the international scientific community with our knowledge.

About Us

Inhalation Sciences Sweden AB (publ.) develops and sells patented, highly innovative labtech equipment for inhalation research. Scientists using it can now know, with unprecedented accuracy, how particles behave in our lungs when we inhale them: whether new pollutants or life-saving drugs that power human development.

Subscribe

Documents & Links